TORQUE Trademark

Trademark Overview

On Monday, August 28, 2017, a trademark application was filed for TORQUE with the United States Patent and Trademark Office. The USPTO has given the TORQUE trademark a serial number of 87585866. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 12, 2020. This trademark is owned by Torque Therapeutics, Inc.. The TORQUE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Manufacturing services for others in the fields of pharmaceuticals and medicine, namely, manufacturing of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells
torque

General Information

Serial Number87585866
Word MarkTORQUE
Filing DateMonday, August 28, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 12, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and ServicesManufacturing services for others in the fields of pharmaceuticals and medicine, namely, manufacturing of biotherapeutics, immunotherapeutics, immunomodulators, immunostimulants, immunogenics, antibodies, cell therapeutics, cells, immune cells, and T-cells

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, September 1, 2017
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTorque Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameTorque Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events

Event DateEvent Description
Tuesday, October 13, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 12, 2020ABANDONMENT - NO USE STATEMENT FILED
Tuesday, March 10, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2020EXTENSION 4 GRANTED
Friday, March 6, 2020EXTENSION 4 FILED
Friday, March 6, 2020TEAS EXTENSION RECEIVED
Thursday, September 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 3, 2019EXTENSION 3 GRANTED
Tuesday, September 3, 2019EXTENSION 3 FILED
Tuesday, September 3, 2019TEAS EXTENSION RECEIVED
Friday, February 22, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 20, 2019EXTENSION 2 GRANTED
Wednesday, February 20, 2019EXTENSION 2 FILED
Wednesday, February 20, 2019TEAS EXTENSION RECEIVED
Monday, February 11, 2019ASSIGNED TO EXAMINER
Friday, January 25, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, January 25, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 15, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 13, 2018EXTENSION 1 GRANTED
Monday, August 13, 2018EXTENSION 1 FILED
Monday, August 13, 2018TEAS EXTENSION RECEIVED
Tuesday, March 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, December 3, 2017ASSIGNED TO LIE
Tuesday, November 21, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 21, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, November 21, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, November 21, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, November 21, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 14, 2017ASSIGNED TO EXAMINER
Friday, September 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 31, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

torque cells manufacturing immunogenics antibodies immunostimulants cell immune therapeutics immunomodulators immunotherapeutics